Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore

Withdrawn before enrolling · Phase 2

Conditions studied: COVID, Coronavirus, COVID-19

In brief

Given the high prevalence of COVID19 illness (both SARS-CoV-2 RT-PCR confirmed and highly suspect cases) among healthcare workers (HCW) within the Montefiore Health System (MHS), hydroxychloroquine (HCQ) will be prescribed to healthcare workers who are at the highest risk for severe COVID19 illness.

Key facts

Study ID

NCT04350450

Run by

Montefiore Medical Center

People needed

0

Starts

2020-04-01

Expected to finish

2020-08-01

Last updated by the study team

2020-05-27

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Symptomatic with COVID illness (either RT-PCR test confirmed or highly suspect clinical symptoms)
• Call into office within the first 7 days of illness
• Have any of the following high risk conditions:
• Age >60
• HTN, CAD, or chronic heart disease
• Diabetes
• Chronic kidney disease
• Chronic lung disease
• Active or recent chemotherapy for malignancy
• Organ transplant
• Taking Immune-suppressing medications
• HIV with CD4 <200 cells/mm3
• Experiencing at least one of the following high risk symptoms:
• Severe cough
• Fever 100.0F or greater
• Diarrhea
• Shortness of Breath
• Hypoxia

You may not qualify if…

• HCW not meeting high-risk criteria or those with a contraindication to HCQ will not be offered HCQ

Where it is running

• Montefiore Medical Center — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.